LY4006896

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4006896, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease [Phase 1]